Sodium-dependent noradrenaline transporter
Details
- Name
- Sodium-dependent noradrenaline transporter
- Kind
- protein
- Synonyms
- NAT1
- NET
- NET1
- Norepinephrine transporter
- SLC6A5
- Solute carrier family 6 member 2
- Gene Name
- SLC6A2
- UniProtKB Entry
- P23975Swiss-Prot
- Organism
- Humans
- NCBI Taxonomy ID
- 9606
- Amino acid sequence
>lcl|BSEQ0000970|Sodium-dependent noradrenaline transporter MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWG KKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYN REGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTW NSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLC LMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFY RLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFA IFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSS MGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTS ILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINF KPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHL VAQRDIRQFQLQHWLAI
- Number of residues
- 617
- Molecular Weight
- 69331.42
- Theoretical pI
- 7.53
- GO Classification
- Functionsactin binding / alpha-tubulin binding / beta-tubulin binding / dopamine / metal ion binding / neurotransmitter / neurotransmitter transmembrane transporter activityProcessesamino acid transport / chemical synaptic transmission / dopamine uptake involved in synaptic transmission / neuron cellular homeostasis / neurotransmitter transport / norepinephrine uptake / response to xenobiotic stimulus / sodium ion transmembrane transportComponentsaxon / cell surface / neuronal cell body membrane / presynaptic membrane
- General Function
- Mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline) (PubMed:2008212, PubMed:8125921). Can also mediate sodium- and chloride-dependent transport of dopamine (PubMed:11093780, PubMed:8125921)
- Specific Function
- actin binding
- Pfam Domain Function
- SNF (PF00209)
- Signal Regions
- Not Available
- Transmembrane Regions
- 63-88 93-116 136-166 234-254 258-282 307-332 339-362 403-428 444-464 466-492 523-545 549-569
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0010343|Sodium-dependent noradrenaline transporter (SLC6A2) ATGCTTCTGGCGCGGATGAACCCGCAGGTGCAGCCCGAGAACAACGGGGCGGACACGGGT CCAGAGCAGCCCCTTCGGGCGCGCAAAACTGCGGAGCTGCTGGTGGTGAAGGAGCGCAAC GGCGTCCAGTGCCTGCTGGCGCCCCGCGACGGCGACGCGCAGCCCCGGGAGACCTGGGGC AAGAAGATCGACTTCCTGCTGTCCGTAGTCGGCTTCGCAGTGGACCTGGCCAACGTGTGG CGCTTCCCCTACCTCTGCTACAAGAACGGCGGCGGTGCCTTCTTGATCCCGTACACACTG TTCCTTATCATCGCGGGGATGCCCCTGTTCTACATGGAGCTGGCTCTGGGACAGTACAAC CGGGAGGGGGCTGCCACCGTTTGGAAAATCTGCCCATTCTTCAAAGGCGTTGGCTATGCT GTCATCCTGATCGCCCTGTACGTTGGCTTCTACTACAACGTCATCATCGCCTGGTCACTC TACTACCTCTTCTCCTCCTTCACCCTCAACCTGCCCTGGACCGACTGTGGCCACACCTGG AACAGCCCCAACTGTACCGACCCCAAGCTCCTCAATGGCTCCGTGCTTGGCAACCACACC AAGTACTCCAAGTACAAGTTCACGCCGGCAGCCGAGTTTTATGAGCGTGGTGTCCTGCAC CTTCACGAGAGCAGCGGGATTCATGACATCGGCCTGCCCCAGTGGCAGCTCTTGCTCTGT CTGATGGTCGTCGTCATCGTCTTGTATTTTAGCCTCTGGAAAGGGGTGAAGACATCAGGA AAGGTGGTGTGGATCACAGCCACGCTGCCTTACTTCGTGCTGTTCGTGCTCCTGGTCCAT GGCGTCACGCTGCCCGGAGCCTCCAATGGCATCAATGCCTACCTGCACATCGACTTCTAC CGCTTGAAAGAGGCCACGGTATGGATTGATGCCGCAACTCAGATATTTTTTTCCTTGGGG GCTGGATTTGGAGTATTGATTGCATTTGCCAGTTACAACAAATTTGACAACAACTGTTAC AGGGATGCCCTGCTGACCAGCAGCATCAACTGTATCACCAGCTTCGTCTCTGGGTTCGCC ATCTTCTCCATCCTTGGTTACATGGCCCATGAACACAAGGTCAACATTGAGGATGTGGCC ACAGAAGGAGCTGGCCTAGTGTTCATCCTGTATCCAGAGGCCATTTCTACCCTGTCTGGA TCTACATTCTGGGCTGTTGTGTTTTTCGTCATGCTCCTGGCGCTGGGCCTTGACAGCTCA ATGGGAGGCATGGAGGCTGTCATCACGGGCCTGGCAGATGACTTCCAGGTCCTGAAGCGA CACCGGAAACTCTTCACATTTGGCGTCACCTTCAGCACTTTCCTTCTCGCCCTGTTCTGC ATAACCAAGGGTGGAATTTACGTCTTGACCCTCCTGGACACCTTTGCTGCGGGCACCTCC ATCCTTTTTGCTGTCCTCATGGAAGCCATCGGAGTTTCCTGGTTTTATGGAGTGGACAGG TTCAGCAACGACATCCAGCAGATGATGGGGTTCAGGCCGGGTCTATACTGGAGACTGTGC TGGAAGTTCGTCAGTCCTGCCTTCCTCCTGTTCGTGGTTGTGGTCAGCATCATCAACTTC AAGCCACTCACCTACGACGACTACATCTTCCCGCCCTGGGCCAACTGGGTGGGGTGGGGC ATCGCCCTGTCCTCCATGGTCCTGGTGCCCATCTACGTCATCTATAAGTTCCTCAGCACG CAGGGCTCTCTTTGGGAGAGACTGGCCTATGGCATCACGCCAGAGAACGAGCACCACCTG GTGGCTCAGAGGGACATCAGACAGTTCCAGTTGCAACACTGGCTGGCCATCTGA
- Chromosome Location
- 16
- Locus
- 16q12.2
- External Identifiers
Resource Link UniProtKB ID P23975 UniProtKB Entry Name SC6A2_HUMAN GenBank Protein ID 189258 GenBank Gene ID M65105 GeneCard ID SLC6A2 GenAtlas ID SLC6A2 HGNC ID HGNC:11048 PDB ID(s) 8HFE, 8HFF, 8HFG, 8HFI, 8HFL, 8Y8Z, 8Y90, 8Y91, 8Y92, 8Y93, 8Y94, 8Y95, 8YR2 KEGG ID hsa:6530 IUPHAR/Guide To Pharmacology ID 926 NCBI Gene ID 6530 - General References
- Pacholczyk T, Blakely RD, Amara SG: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 1991 Mar 28;350(6316):350-4. [Article]
- Porzgen P, Bonisch H, Bruss M: Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun. 1995 Oct 24;215(3):1145-50. [Article]
- Porzgen P, Bonisch H, Hammermann R, Bruss M: The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons. Biochim Biophys Acta. 1998 Jul 9;1398(3):365-70. [Article]
- Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article]
- Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC, Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA: The sequence and analysis of duplication-rich human chromosome 16. Nature. 2004 Dec 23;432(7020):988-94. [Article]
- Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG: Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 2001 Apr;30(1):121-34. [Article]
- Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D: Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000 Feb 24;342(8):541-9. [Article]
Associated Data
- Drug Relations
Drug Drug group Pharmacological action? Type Actions Details Phentermine approved, illicit yes target inhibitor Details Reboxetine approved, experimental yes target inhibitor Details Atomoxetine approved yes target inhibitor Details Protriptyline approved yes target inhibitor Details Imipramine approved yes target inhibitor Details Mazindol approved, investigational yes target inhibitor Details Phenmetrazine approved, illicit yes target inhibitor Details Diethylpropion approved, illicit yes target inhibitor Details Tramadol approved, investigational yes target inhibitor Details Guanadrel approved yes target partial agonist Details Venlafaxine approved yes target inhibitor Details Amitriptyline approved yes target inhibitor Details Methylphenidate approved, investigational unknown target inhibitor Details Duloxetine approved yes target inhibitor Details Nortriptyline approved yes target inhibitor Details Amoxapine approved yes target inhibitor Details Trimipramine approved yes target inhibitor Details Cocaine approved, illicit yes target inhibitor Details Maprotiline approved, investigational yes target inhibitor Details Sibutramine approved, illicit, investigational, withdrawn yes target inhibitor Details Doxepin approved, investigational yes target inhibitor Details Nefazodone approved, withdrawn yes target inhibitor Details Desipramine approved, investigational yes target inhibitor Details Bupropion approved yes target inhibitor Details Guanethidine approved yes target inducer Details Clomipramine approved, investigational, vet_approved unknown target inhibitor Details Paroxetine approved, investigational unknown target inhibitor Details Amineptine illicit, withdrawn unknown target Details Debrisoquine approved, investigational yes target inducer Details Bicifadine investigational yes target modulator Details Milnacipran approved, investigational yes target inhibitor Details XEN-2174 investigational unknown target Details CRx-119 investigational unknown target Details Dasotraline investigational yes target inhibitor Details Tesofensine investigational unknown target Details Amitifadine investigational yes target inhibitor Details DDP-225 investigational unknown target Details Tapentadol approved yes target inhibitor Details Trodusquemine investigational unknown target Details Nomifensine approved, withdrawn unknown target Details Escitalopram approved unknown target inhibitor Details Chlorpheniramine approved unknown target inhibitor Details Ginkgo biloba approved, investigational, nutraceutical unknown target inhibitor Details Orphenadrine approved yes target inhibitor Details Desvenlafaxine approved, investigational yes target inhibitor Details Mianserin approved, investigational unknown target inhibitor Details Dexmethylphenidate approved, investigational yes target inhibitor Details Pseudoephedrine approved yes target inhibitor Details Dextroamphetamine approved, illicit yes target negative modulator Details Phendimetrazine approved, illicit yes target negative modulator Details Ephedra sinica root nutraceutical yes target negative modulator Details MMDA experimental, illicit yes target negative modulator Details Metamfetamine approved, illicit, withdrawn yes target negative modulator Details Midomafetamine experimental, illicit, investigational yes target negative modulator Details Ephedrine approved unknown target inverse agonist Details Norepinephrine approved unknown transporter substrate Details Droxidopa approved, investigational unknown transporter substrate Details Midomafetamine experimental, illicit, investigational unknown transporter Details Iobenguane approved, investigational no transporter substrate Details Levomilnacipran approved, investigational yes target inhibitor Details Loxapine approved unknown target binder Details Amphetamine approved, illicit, investigational unknown target agonistsubstrate Details Dextromethorphan approved unknown target inhibitor Details Dopamine approved unknown target inhibitor Details Meperidine approved unknown target inhibitor Details Ketamine approved, vet_approved unknown target inhibitor Details Vortioxetine approved, investigational unknown target blocker Details Iobenguane sulfate I-123 approved, investigational no transporter substrate Details Dosulepin approved yes target inhibitor Details Viloxazine approved, investigational, withdrawn yes target inhibitor Details Etoperidone withdrawn no transporter inhibitor Details Netarsudil approved yes target inhibitor Details Zotepine approved, investigational, withdrawn yes target antagonist Details Rauwolfia serpentina root investigational unknown transporter inhibitor Details Benzatropine approved no target inhibitor Details Solriamfetol approved unknown target Details Cyclobenzaprine approved unknown target inhibitor Details Sertraline approved unknown target inhibitordownregulator Details Pseudoephedrine approved unknown transporter inhibitor Details Nortriptyline approved unknown transporter substrateinhibitor Details Procaine approved, investigational, vet_approved unknown transporter inhibitor Details Serdexmethylphenidate approved yes target inhibitor Details Tenamfetamine experimental, illicit yes target inhibitor Details Nisoxetine experimental yes target inhibitor Details Seproxetine investigational yes target inhibitor Details Radafaxine investigational yes target inhibitor Details Esreboxetine investigational yes target blocker Details NS-2359 investigational yes target inhibitor Details Iobenguane approved, investigational yes target modulator Details Ampreloxetine investigational yes target modulator Details Acetaminophen approved yes target inhibitor Details